Stay updated on Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial page.

Latest updates to the Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial page
- Check2 days agoChange DetectedThe page’s displayed revision/version number in the footer was updated from v3.5.2 to v3.5.3, reflecting a minor site release update without altering the study details.SummaryDifference0.1%

- Check9 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0 on the page header.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check74 days agoChange DetectedOnly administrative metadata and revision notes were updated or removed; the ClinicalTrials.gov study content, eligibility criteria, outcomes, and trial timeline remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check81 days agoChange DetectedA site-wide notice about a lapse in government funding was added, and the page version was updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial page.